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ABSTRACT 
Background & Aims: Evidence on the association between physical activity and risk of 
hepatobiliary cancers is inconclusive. We examined this association in the European 
Prospective Investigation into Cancer and Nutrition cohort (EPIC). 
Methods: We identified 275 hepatocellular carcinoma (HCC) cases, 93 intrahepatic bile duct 
cancers (IHBC), and 164 non-gallbladder extrahepatic bile duct cancers (NGBC) among 
467,336 EPIC participants (median follow-up 14.9 years). We estimated cause-specific hazard 
ratios (HRs) for total physical activity and vigorous physical activity, performed mediation 
analysis, and secondary analyses to assess robustness to confounding (e.g., due to hepatitis 
virus infection).  
Results: In the EPIC cohort, the multivariable-adjusted HR of HCC was 0.55 (95% confidence 
intervals (CI) 0.38-0.80) comparing active and inactive individuals. Regarding vigorous physical 
activity, for those reporting >2 hours/week compared to those with no vigorous activity, the HR 
for HCC was 0.50 (0.33-0.76). Estimates were similar in sensitivity analyses for confounding. 
Total and vigorous physical activity were unrelated to IHBC and NGBC. In mediation analysis, 
waist circumference explained about 40% and body mass index 30% of the overall association 
of total physical activity and HCC.  
Conclusions: Findings suggest an inverse association between physical activity and risk of 
HCC, which is potentially mediated by obesity. 
Lay summary: In a pan-European study of 467,336 men and women, we found that physical 
activity is associated with a reduced risk of developing liver cancers over the next decade. This 
risk was independent of other liver cancer risk factors, and did not vary by age, gender, 
smoking status, body weight, and alcohol consumption. 
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Graphical abstract 
> 
Highlights 
 Liver cancer rates are increasing in Western countries, possibly due to increases in 
obesity, diabetes, and physical inactivity. 
 Previous evidence was not convincing to support an effect of physical activity on liver 
cancer. 
 We found that physical activity reduced the risk of hepatocellular carcinoma by about 
45%. 
 
Abbreviations: BMI, body mass index; CI, confidence interval; DNA; deoxyribonucleic acid; 
EPIC, European Prospective Investigation into Cancer and Nutrition cohort; EPIC-PAQ, 
European Prospective Investigation into Cancer and Nutrition cohort physical activity 
questionnaire; g/d, grams per day; HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, 
hepatocellular carcinoma; HR, hazard ratio; IHBC, intrahepatic bile duct cancers; MEDLINE, 
Medical Literature Analysis and Retrieval System Online; NGBC, non-gallbladder extrahepatic 
bile duct cancers; RR, relative risk; SD, standard deviation; US, United States of America; 
WCRF, World Cancer Research Fund International.  
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Introduction 
Liver cancer was the fourth leading cause of cancer death in 2015 [1]. Liver cancer is 
responsible for around 47,000 deaths per year in the European Union [2]. Hepatocellular 
carcinoma (HCC) is the most common type of primary liver cancer derived from hepatocytes 
and it accounts for 85-90% of all primary liver cancers worldwide. It is the fifth most common 
cancer in men and the seventh most common cancer in women [1]. The distribution of HCC 
varies greatly according to geographic location and it is more common in low- and middle-
income countries than in developed countries. HCC more frequently occurs in Asia and Africa 
than in Europe and the US. The strongest risk factor for HCC is cirrhosis, a condition that is 
related to Hepatitis B virus (HBV), Hepatitis C virus (HCV), excessive consumption of alcohol, 
and exposure to aflatoxin B1 [1]. The geographic variability of HCC incidence has been widely 
associated to the different distribution of HBV and HCV infections [1, 3]. In high-income 
countries, the main risk factors for HCC are smoking, alcoholic cirrhosis, diabetes, obesity, and 
non-alcoholic hepatic steatosis [1, 4, 5]. The recent increase in HCC incidence is thought to be 
caused by increases in obesity, diabetes, and physical inactivity [6, 7]. The Physical Activity 
Collaboration of the National Cancer Institute’s Cohort Consortium performed a pooled analysis 
of 10 prospective US and European cohorts and found that high compared to low leisure-time 
physical activity was associated with a 27% lower risk of liver cancer incidence [8]. Other 
prospective studies from the US and East Asian countries support an association of physical 
activity and lower risk of hepatobiliary cancers [8-13]. However, the World Cancer Research 
Fund International judged that the evidence was not convincing to support an effect of physical 
activity on liver cancer [14]. Similarly, an umbrella review provided limited evidence for an 
association with liver cancer [15]. We report results from the EPIC (European Prospective 
Investigation into Cancer and Nutrition) cohort to provide additional evidence on the 
relationship between physical activity and HCC and other hepatobiliary cancers. 
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Methods 
Study Population and Data Collection 
The EPIC is a multinational prospective cohort study designed to investigate the link between 
diet, lifestyle and environmental factors with cancer risk and other chronic diseases. Detailed 
information on the study design, rationale, and methods of the EPIC cohort has been described 
previously [16]. Briefly, between 1992 and 2000, >520 thousand men and women, aged 25-70 
years, were recruited from 23 centers throughout 10 countries (Denmark, France, Germany, 
Greece, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom). Data on 
physical activity, education, smoking, alcohol consumption, coffee intake, anthropometric 
measurements and medical history were collected at baseline, before disease onset or 
diagnosis. All cohort members provided written informed consent. Ethics approval was obtained 
from the International Agency for Research on Cancer review board (Lyon, France) and 
participating centers. A total of 467,336 participants were included in the main analyses for total 
physical activity and hepatobiliary cancer risk after the following exclusions: 25,184 participants 
with prevalent cancer other than non-melanoma skin cancer; 20 subjects with missing date of 
diagnosis; and 4,128 individuals without follow-up. Four EPIC study centers (Naples, Umea, 
South-East of Norway, North-West of Norway) did not measure vigorous physical activity. Thus, 
the analysis of vigorous physical activity and hepatobiliary cancer risk was limited to 341,533 
participants for whom data on this exposure were available. 
In a subset [17] of the EPIC cohort as of 2006, sera samples for HBV (ARCHITECT HBsAg, 
Abbott Diagnostics, France) and HCV (anti-HCV chemiluminescent microparticle 
immunoassays, Abbott Diagnostics, France) serologic tests were available: 115 HCC cases 
were matched using incidence density sampling to 230 controls based on age at blood 
collection, sex, study center, time of the day at blood collection, fasting status at blood 
collection; among women, additionally by menopausal status, and hormone replacement 
therapy use at time of blood collection. These data were used in nested case-control analyses 
to examine potential confounding by viral hepatitis status for the association of physical activity 
and HCC.  
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Follow-up of Study Population and Case Ascertainment 
Incident first primary hepatobiliary cancer cases and vital status were ascertained through 
record linkage with cancer and death registries in most centers [16]. In France, Germany and 
Greece, ascertainment was done using a combination of methods including health insurance 
records, pathology registries and active follow-up through mailed questionnaires/telephone 
interviews [16]. Incident cancers were subsequently verified through medical records, pathology 
reports and discharge diagnosis [16]. In all centers, cancer diagnosis required confirmation 
through comprehensive pathology review [16]. A detailed protocol entitled ‘Guidelines for 
Collection of End-point Data in the EPIC study‘ for the collection and standardization of clinical 
and pathological data for each cancer site was prepared by a special EPIC working group [16]. 
Cancer incidence was coded according to the International Classification of Diseases-
Oncology-2. HCC was defined as C22.0. Cancer of the intrahepatic bile duct (IHBC) was 
defined as C22.1. Non-gallbladder extrahepatic bile duct tract cancer (NGBC) was defined as 
tumors in the extrahepatic bile duct (C24.0), Ampulla of Vater (C24.1) or overlapping lesions of 
the biliary tract (C24.8), and the biliary tract not specified (C24.9). We did not consider cancers 
of the gallbladder (C23.9) as an endpoint because we assumed different underlying 
mechanisms [10]. 
Assessment of Physical Activity 
The validated EPIC physical activity questionnaire (EPIC-PAQ) was used to assess 
recreational, household and occupational physical activity during the past year in all EPIC 
centers, except in the Norwegian centers [18-20]. Recreational physical activity was assessed 
by querying about the amount of time in hours per week during the winter and summer spent 
with cycling and other physical exercises (e.g., jogging, swimming) and was summarized into 
four groups: inactive, moderately inactive, moderately active, and active [21, 22]. Participants 
reported their level of occupational physical activity as either sedentary, standing, manual work 
or heavy manual work. They were also asked whether engaging in household and recreational 
activities had caused them to experience increases in sweating or heartbeat, and, if so, how 
many hours per week they dedicated to these vigorous activities. We derived measures of total 
  
9 
 
physical activity and vigorous physical activity from the EPIC-PAQ. The Cambridge Index was 
used as a measure of total physical activity by combining recreational physical activity and 
occupational physical activity [20, 22]. The Cambridge Index was developed [22] and validated 
[19] by comparing the EPIC-PAQ with objective measures of cardiorespiratory fitness and 
physical activity energy expenditure. The Spearman correlation between the Cambridge Index 
and physical activity energy expenditure was 0.33 (95% confidence interval: 0.28 to 0.38) [19]. 
The Norwegian EPIC centers measured total physical activity using a scale that ranged from 1 
to 10 [23]; and the Cambridge Index for the Norwegian centers was derived as described 
previously [21]. Vigorous physical activity was categorized into 0, ≤2 (below the median), or >2 
(above the median) hours per week [21, 24]. 
Statistical Analysis 
Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using cause-specific Cox 
proportional hazard models, with age as the underlying time metric. Time of study entry was 
age at recruitment and exit time was age at cancer diagnosis or the last date at which follow-up 
was considered complete in each center. Models were stratified by center and sex to minimize 
departure from proportionality and to control for differences between centers, such as follow-up 
procedures and questionnaire design. Trend tests across exposure groups were performed by 
modeling the categorical physical activity variables as continuous covariables. We estimated 
cumulative incidence functions, adjusted for baseline confounders, accounting for competing 
risk of death from causes other than hepatobiliary cancer using a Fine-Gray subdistribution 
hazard model. The basic multivariable models were adjusted for education (no school degree, 
primary school, technical/professional/secondary, university), smoking status and intensity 
(never, current [1 to 15, 16 to 25, or ≥26 cigarettes/day], or former [≤10 or >10 years]; current 
pipe, cigar or occasional smoking), current alcohol consumption (grams per day (g/d) modeled 
continuously using restricted cubic splines), lifetime alcohol use patterns (never, former, >0 – 6 
[men]/> 0 – 3 [women], >6-12 [men]/>3-12 [women], >12-24, >24 – 60, > 60 g/d), and daily 
number of cups of coffee (1 cup was defined as 150 mL). For covariates with missing data (see 
Table 1), multiple imputation of covariates by fully conditional specification with accommodation 
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of the substantive model [25] and 25 sets of imputed data was used. We examined 
multiplicative effect modification by testing interaction terms of physical activity variables with 
sex, age (continuous), waist circumference (continuous), body mass index (continuous), 
baseline alcohol consumption (continuous) and lifetime alcohol consumption (categorical) using 
likelihood ratio tests; for continuous covariates a procedure based on fractional polynomials 
was used [26]. 
Because obesity and diabetes may be potential intermediates [4, 27, 28], our primary 
multivariable model did not control for them. Causal mediation analysis methods, as described 
for survival data [29], were used to examine the proportions of the association of physical 
activity with hepatobiliary cancer risk that was mediated by waist circumference, body mass 
index, and diabetes. These mediators were selected a priori based on subject knowledge [4, 
27, 28] and were assessed using multiple linear regression (waist circumference, body mass 
index) and logistic regression (diabetes) for the mediator models and accelerated failure time 
models with Weibull distribution for time to event [29, 30]. Proportion mediated was calculated 
as indirect natural effect divided by the sum of the direct and indirect natural effect [29] and 500 
simulations were used to derive quasi-Bayesian CI [30]. To facilitate the interpretation of 
mediation analyses, the categories ‘active’ vs. ‘inactive’ of the Cambridge Index and ‘>2 
hours/week’ vs. ‘no’ vigorous physical activity were compared. The mediation method assumes 
no unmeasured confounding in the exposure-outcome, mediator-outcome, and exposure-
mediator relations, and no effect of the exposure on confounders of the mediator-outcome 
relation. We did not detect any exposure-mediator interactions.  
We conducted several sensitivity analyses to test the robustness of our primary models. First, 
to minimize the influence of reverse causation, we excluded hepatobiliary cancer events that 
occurred during the first two years of follow-up. Second, although our primary analysis 
assumed that obesity and diabetes mediate the association of physical activity and 
hepatobiliary cancer risk, it is also plausible to hypothesize that overweight/obesity and 
diabetes render physical activity difficult (i.e., confound the association) [31]. Accordingly, we 
performed secondary analyses with additional adjustment for waist circumference and 
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diabetes. Third, we assessed the robustness of observed associations to unmeasured 
confounding. Specially, we calculated E-Values [32], which indicate the minimum strength of 
association than an unmeasured confounder would need to have with the exposure and the 
outcome on the risk ratio scale to fully account for an observed exposure-outcome association, 
above and beyond the measured covariates. Additionally, we used data from the EPIC nested 
case-control study [17] to adjust associations for HBV/HCV status. Odds ratios (OR) for HCC 
were derived from multivariable conditional logistic regression, adjusted for matching variables, 
age, sex, smoking status, current alcohol use, and coffee intake. Analysis of the nested case-
control subset was performed among all subjects with additional adjustment for HBC/HCV; and 
among HBC/HCV negative individuals. Fourth, as an alternative to the stratified Cox model, we 
modeled unobserved heterogeneity across centers using a Cox model with a shared frailty. 
Fifth, due to different assessment of total physical activity in the Norwegian centers, we re-
estimated our Cox models for total physical activity after excluding data from the Norwegian 
centers. Sixth, we performed complete cases analysis when covariates had missing values. P 
values < 0.05 are reported as statistically significant. Analyses were performed using R 
(version 3.5.1), SAS (version 9.4), and Stata (version 15.1). 
Results  
EPIC Study 
Characteristics of Participants 
Among the 467,336 participants in the EPIC study, the mean (SD) age was 51.3 (9.9) years, 
and 70.2% were women. During a median follow-up time of 14.9 years, participants contributed 
6,508,182 person years, and 275 HCC, 93 IHBC, and 164 NGBC cancer cases occurred. Age-
adjusted baseline characteristics of the analytical sample are provided in Table 1. 
Physical Activity and Hepatobiliary Cancer Risk 
Total physical activity and vigorous physical activity were inversely associated with HCC but not 
with IHBC and NBGC. The adjusted HR for HCC comparing ‘active’ and ‘inactive’ individuals 
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was 0.55 (95% CI: 0.38 to 0.80, P for Trend < 0.001) (Table 2). The adjusted HR of HCC for ‘>2 
hours/week’ of vigorous activity vs. no vigorous activity was 0.50 (95% CI: 0.33 to 0.76, P for 
Trend <0.001) for HCC (Table 3). The adjusted cumulative incidence functions indicate that the 
physically inactive group showed excess HCC incidence compared to more active groups 
(Figure 1). The relations of total physical activity and vigorous physical activity with outcomes 
were not modified by sex, age, waist circumference, body mass index, smoking, current alcohol 
consumption or lifetime alcohol consumption (all P for interaction >0.1). 
Mediation of the Association between Physical Activity and HCC Risk 
We used mediation analysis to estimate the proportions of the associations with HCC that were 
mediated by waist circumference, body mass index, and diabetes (Table 4). Waist 
circumference explained 40% and body mass index 30% of the overall association of total 
physical activity and HCC. The proportions of the total effect of vigorous physical activity on 
HCC mediated by waist circumference and body mass index were 17% and 12%, respectively. 
Diabetes did not seem to mediate the observed associations. 
Sensitivity Analyses 
In sensitivity analyses, the associations of total physical activity and vigorous physical activity 
with HCC, IHBC and NBGC were virtually unchanged when events occurring during the first 
two years of follow-up were excluded (Supplementary Tables 1 and 2). In models additionally 
adjusted for waist circumference and diabetes, the HR for HCC were attenuated but remained 
statistically significant. In the Cox model for total physical activity and HCC, for an unmeasured 
confounder to explain the HR estimate of 0.55, the unmeasured confounder would have to 
increase the likelihood of physical activity and decrease the likelihood of HCC by 3.0-fold, 
above and beyond the measured confounders. For an unmeasured confounder to bring up the 
upper confidence limit of 0.80 for this estimate to above 1.0, the unmeasured confounder would 
still have to both increase the likelihood of physical activity and decrease the likelihood of HCC 
by 1.8-fold, conditional on the measured covariates. Similarly, an unobserved confounder 
would need to be associated with a RR of 3.4 with vigorous physical activity and HCC to 
  
13 
 
explain the estimated HR of 0.50 and a RR of 1.9 to move the upper confidence limit above 1.0, 
conditional on the measured covariates. We used the EPIC nested case-control study to 
perform additional adjustment for HBV/HCV. The results of these analyses were similar in 
direction and magnitude to those reported for the entire cohort, but they were not statistically 
significant, due to small sample size (Supplementary Table 3). However, the data from the 
case-control dataset provide further support for the notion that additional confounding by 
HBV/HCV might not be sufficient to explain away the observed association of physical activity 
and HCC. Estimates from frailty models to account for between-center heterogeneity were 
similar those from the stratified Cox models. After exclusion of Norwegian centers and in 
complete case analyses, HR were almost identical to the primary analysis. The HR and CI from 
the complete case analyses were similar to those from primary models employing multiple 
imputation (Supplement Tables 1 and 2). 
Discussion 
In this analysis of a multinational European cohort, higher total physical activity and vigorous 
physical activity were associated with lower risk of HCC. We observed a 45% lower risk of HCC 
when comparing high and low levels of total physical activity. The highest level of vigorous 
physical activity was associated with a 50% lower risk for HCC. Moreover, we observed that 
inverse associations of total physical activity and vigorous physical activity with HCC did not 
differ substantially between subgroups based on gender, lifestyle, and anthropometric 
variables. Findings from the sensitivities analyses suggest that the association of physical 
activity and HCC might be robust to reverse causation and unobserved confounding (e.g., by 
hepatitis virus infection). Our study also explored the roles of obesity and diabetes in physical 
activity’s association with HCC. Our findings indicate that waist circumference mediated about 
40% and BMI about 30% of the overall association of total physical activity and HCC. In 
contrast, diabetes did not seem to play an important role as a mediating factor. 
These findings are in line with a pooled analysis of 10 cohorts with a total of 1,384 cases that 
reported a 27% lower risk of liver cancer comparing high and low levels of leisure time physical 
activity [8]. In the NIH-AARP Diet and Health Study, high versus no vigorous physical activity 
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was related to a 44% lower risk of HCC [10]. Similar to our study, no association between 
physical activity and biliary tract cancer was shown in a previous analysis of NIH-AARP Diet 
and Health Study [10]. 
Several biological mechanisms might explain the inverse association between physical activity 
and hepatobiliary cancer, including systemic and local effects [28, 33]. The interrelated 
mechanisms most extensively studied are changes in whole-body and visceral fatness, 
metabolic dysregulation (e.g., insulin, glucose, insulin-like growth factors), adipokines (e.g., 
leptin, adiponectin), sex hormones (e.g., estrogen, testosterone), chronic low-grade 
inflammation, oxidative stress causing DNA damage and gene mutations (e.g., tumor 
suppression genes), impaired immune function, diluting effects on carcinogenic bile acids, and 
decreased intestinal transit time [33-35]. Evidence from prospective observational studies and 
randomized controlled trials suggests that the most relevant mechanism by which physical 
activity positively affects liver cancer risk is lowering body weight [27, 36-38]. The present study 
systematically explored the role of markers of overall adiposity (BMI), indirect measures of 
central obesity (waist circumference) and metabolic dysregulation (diabetes) in the overall 
association between physical activity and HCC. We found that central obesity might account for 
a large proportion of the direct effect of physical activity on HCC. The mechanisms underlying 
the association between central obesity and hepatobiliary cancer, particularly HCC, may occur 
through accumulation of excessive liver fat that increases pro-inflammatory molecules, leptin, 
and adiponectin [27]. 
The analysis of this large multinational European cohort provided sufficient events to examine 
the association of physical activity with hepatobiliary cancers. The cohort study also provided 
first insights into the relative importance of different intensities of physical activity. We 
performed sensitivity analyses to address potential selection bias, differences in case 
ascertainment between centers, and additional unobserved confounding. Although HBV and 
HCV are considered among the strongest risk factors for HCC [3], previous studies [8-13, 37] 
were unable to adjust for HBV and HCV. In the EPIC nested case control study the size and 
direction of the effect size for the association of physical activity and HCC was similar to that of 
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the entire EPIC cohort; however, it was not statistically significant. Our sensitivity analyses for 
unobserved confounding using E-Values [32] further support the notion that any unmeasured 
confounding would need to be substantial to explain the inverse association of physical activity 
and HCC. The study had additional limitations. We were not able to adjust for other potentially 
important confounding factors (e.g., pleiotropic effects of statins) and to examine the role of 
intermediate phenotypes (non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, 
cirrhosis). Further, compared to the general population, women were overrepresented in our 
sample, although men have higher risk of HCC [39]. Another limitation is that we were not able 
to examine in detail the type, intensity and amount of physical activity needed to reduce HCC 
risk. Physical activity and anthropometric measures were assessed only once at baseline. 
Repeated measurements of physical activity, anthropometric measures, and other potential 
biological intermediates over time would have strengthen our understanding of the underlying 
mechanisms. A recent analysis of the NIH-AARP Diet and Health Study [9] revealed that 
consistent participation in physical activity throughout the life course might be needed to reduce 
the risk of liver cancer incidence. We performed mediation analysis for indirect effects acting 
through general and central obesity, but we were unable to study trajectories of physical activity 
and body weight that could help to better separate the role of obesity as a confounder and 
mediator of the association of physical activity and risk of hepatobiliary cancer [8].  
In conclusion, our analysis suggests that physical activity reduces risk of HCC. Studies with 
more detailed and objectively measured physical activity assessed at multiple time points 
throughout the life course are warranted to confirm our findings and may help establish the 
optimal dose, type, intensity, and timing of physical activity that is needed to prevent HCC.  
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Table 1 Age-adjusted Baseline Characteristics of the EPIC Cohort by Total Physical Activity (n = 467,336) 
  
Total physical activity (Cambridge Physical Activity Index) 
 
Total N Inactive Moderately inactive Moderately active Active 
Vigorous Physical Activity (%)      
None 182,178 55.9 42.5 30.0 28.5 
≤2 hours/week 88,245 18.1 19.9 19.0 18.7 
>2 hours/week 71,110 11.2 14.6 17.0 17.1 
Missing 125,803 14.8 23.0 34.0 35.7 
Sex (%)      
Men 139,168 26.8 27.7 27.5 40.4 
Women 328,168 73.2 72.3 72.5 59.6 
Education (%)      
No school degree/ unknown 20,859 7.3 3.7 3.6 4.2 
Primary school 120,284 35.7 23.1 23.1 25.8 
Technical/professional/secondary 198,720 40.0 43.7 43.8 43.6 
University 112,121 15.6 26.3 26.8 24.1 
Missing 10,658 1.3 2.6 2.6 2.3 
Smoking (%)      
Never 20,2567 48.6 43.5 40.9 40.5 
Current      
<15 cigarettes/day 53,680 10.2 11.1 12.1 12.9 
≥15 cigarettes/day 37,534 9.4 7.7 7.4 7.9 
Current pipe, cigar or occasional smoking 40,040 7.3 9.6 9.4 6.8 
Former      
<10 years 44,584 8.2 9.4 9.9 10.8 
≥10 years 75,403 13.6 16.0 16.9 18.4 
Missing 13,528 2.6 2.7 3.4 2.8 
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Baseline alcohol consumption (g/d)  3.1 5.8 5.4 7.3 
Average Lifetime alcohol consumption (g/d)      
Non-drinkers 28,146 8.7 6.4 4.3 4.6 
Former 17,026 5.1 3.9 2.7 2.9 
>0 – 6 (M)/> 0 – 3 (W) 93,442 25.4 21.3 16.3 17.2 
>6-12(M)/>3-12(W) 110,070 24.6 24.3 22.2 22.6 
>12-24 63,487 12.0 13.4 14.3 14.2 
>24 – 60 41,822 7.2 8.6 10.1 9.8 
>60 8,977 1.5 1.8 2.2 2.2 
Missing 104,366 15.4 20.2 27.8 26.4 
Coffee (ml/d)  179.3 281.1 316.9 409.4 
Waist circumference (cm)  87.2 83.3 82.9 84.2 
Missing 108,439     
Body mass index (kg/m²)      
Missing 82,692 26.4 25.1 24.8 24.9 
Diabetes (%)  5.4 2.6 2.0 1.9 
Missing 36,517     
EPIC, European Prospective Investigation into Cancer and Nutrition. Entries are adjusted medians for continuous variables and adjusted percentages for categorical variables. Adjustment for age using 
median regression (continuous covariates), binary logistic regression (dichotomous covariates), ordinal logistic regression (ordered categorical covariates), multinomial logistic regression (unordered 
categorical covariates)
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Table 2 Association of Total Physical Activity and Hepatocellular Carcinoma (HCC), 
Intrahepatic Bile Duct Cancers (IHBC) and Non-Gallbladder Biliary Tract Cancer 
(NGBC) Risk in the EPIC cohort (n = 467,336) 
 
Total Physical Activity (Cambridge Index) 
P 
Value 
for 
Trend 
 
Inactive  
(Reference) 
Moderately 
inactive Moderately active Active 
HCC (n) 91 83 48 53  
HR (95% CI) 1.00 0.65 (0.48-0.89) 0.49 (0.34-0.71) 0.55 (0.38-0.80) <0.001 
IHBC (n) 26 27 21 19  
HR (95% CI) 1.00 0.72 (0.41-1.26) 0.66 (0.36-1.21) 0.82 (0.43-1.53) 0.477 
NGBC (n) 39 46 36 43  
HR (95% CI) 1.00 0.67 (0.43-1.05) 0.67 (0.42-1.08) 0.88 (0.55-1.39) 0.761 
EPIC, European Prospective Investigation into Cancer and Nutrition. HCC, hepatocellular carcinoma (C22.0). IHBC, intrahepatic 
bile duct cancers (C22.1). Non-gallbladder extrahepatic bile duct tract cancer (NGBC, C24.0, C24.1, C24.8, C24.9). HR (cause-
specific hazard ratio) from center-and sex stratified Cox proportional hazards model, age as time metric, adjusted for education, 
smoking, baseline alcohol consumption, lifetime alcohol consumption, coffee. Missing covariate data was imputed using multiple 
imputation. 
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Table 3 Association of Vigorous Physical Activity and Hepatocellular Carcinoma (HCC), 
Intrahepatic Bile Duct Cancers (IHBC) and Non-Gallbladder Biliary Tract Cancer 
(NGBC) Risk in the EPIC cohort (n = 341,533) 
HR (95% CI) 
Vigorous Physical Activity 
P Value 
for 
Trend 
 None 
(Reference) ≤2 hours/week >2 hours/week 
 
HCC (n) 122 33 32  
HR (95% CI) 1.00 0.50 (0.33-0.75) 0.50 (0.33-0.76) <0.001 
IHBC (n) 46 11 14  
HR (95% CI) 1.00 0.52 (0.26-1.06) 0.75 (0.39-1.44) 0.271 
NGBC (n) 64 26 24  
HR (95% CI) 1.00 0.78 (0.47- 1.30) 0.80 (0.48-1.35) 0.368 
EPIC, European Prospective Investigation into Cancer and Nutrition. HCC, hepatocellular carcinoma (C22.0). IHBC, intrahepatic 
bile duct cancers (C22.1). Non-gallbladder extrahepatic bile duct tract cancer (NGBC, C24.0, C24.1, C24.8, C24.9). HR (cause-
specific hazard ratio) from center-and sex stratified Cox proportional hazards model, age as time metric, adjusted for education, 
smoking, baseline alcohol consumption, lifetime alcohol consumption, coffee. Missing covariate data was imputed using multiple 
imputation. 
  
23 
 
Table 4 Mediation Analysis for the Association of Total Physical Activity and Vigorous Physical Activity and Hepatocellular Carcinoma (HCC)  
in the EPIC cohort 
 Total Physical Activity (Cambridge Index) (n 
= 363,228) 
Vigorous Physical Activity 
(n = 275,433) 
Mediator Proportion 
Mediated, % P Value for Indirect Effect 
Proportion 
Mediated, % P Value for Indirect Effect 
Waist Circumference 40.0 0.02 16.7 0.01 
Body Mass Index 29.7 0.02 11.9 <0.01 
Diabetes 4.2 0.21 0.6 0.23 
EPIC, European Prospective Investigation into Cancer and Nutrition. HCC, hepatocellular carcinoma (C22.0). Adjusted for age, sex, education, smoking, baseline alcohol consumption, lifetime alcohol 
consumption, and coffee intake. Complete-case analysis was used for mediation analysis. 
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Figure 1 Cumulative Incidence of HCC according to Total Physical Activity and Vigorous 
Physical Activity 
 
Adjusted cumulative incidence from a Fine-Gray model, with age as time metric, adjusted for education, smoking, baseline 
alcohol consumption, lifetime alcohol consumption, and coffee. 
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Highlights 
 Liver cancer rates are increasing in Western countries, possibly due to increases in 
obesity, diabetes, and physical inactivity. 
 Previous evidence was not convincing to support an effect of physical activity on liver 
cancer. 
 We found that physical activity reduced the risk of hepatocellular carcinoma by about 
45%. 
 
 
